Adaptive-design Dose Finding Study to Assess the Antiviral Efficacy and Safety of NIM811 Administered in Combination With Standard of Care (SOC) in Relapsed Hepatitis C Virus 1 (HCV-1) Infected Patients
Clinical trial NCT00983060 · COMPLETED
Trial details
- NCT number
- NCT00983060
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2011-04-01
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.